Blog
Revolutionizing Cell Therapy Manufacturing: Cheaper and Accessible
📰 Getting the Economical Edge on Cheaper Cell Therapy Manufacturing explores Alder Therapeutics' cost-effective approach to therapy development. 💰🔬🧪🔬🔬🌱
Revolutionizing Bioprocessing: Streamlining Quality Control
📰 Biopharma companies prioritize bioburden control in continuous bioprocessing to ensure product quality. 🧪 Integrated testing expedites detection and eliminates errors. 👩🔬 User requirements aid in fault detection. 💡 Timely decision-making is crucial. 📊 Managing data and implementing a two-tiered control system are key challenges. 👉 New equipment and automation facilitate in-process bioburden testing.
Unveiling the Secret to Sustainable Bioprocessing!
🌱 The bioprocessing industry is striving for sustainability, but its environmental impact remains uncertain. 🌍 Optimizing processes and reducing waste are key. 🚀
Revolutionary Dog Snack: Highly Nutritious and Eco-Friendly!
🐾 Discover the future of dog snacks! 🌱🐶 German-Portuguese start-up MicroHarvest and VEGDOG are revolutionizing pet food with sustainable protein!
Revolutionary Partnership Automates Cell Therapy Manufacturing for Age-Related Diseases
🙌 Multiply Labs and Retro Biosciences partner to automate cell therapy manufacturing for age-related diseases, valued at $85 million. 🌍
Game-Changing $21B Alzheimer’s Therapy Deal Sealed!
AC Immune and Takeda join forces 🤝💼🧠, sealing a $2.1bn deal for ACI-24.060 therapy to combat Alzheimer's disease.
CEO of Généthon Reveals Future of Gene Therapy
🔍 Frédéric Revah, CEO of Généthon, reflects on the past, present, and future of the organization in an interview. 🧬 Généthon was created in 1990 with a focus on gene therapy research for rare genetic diseases. 💡 Revah discusses the challenges of financing development for rare diseases and the need for equity in distribution. 🏭 Généthon is working on improving bioprocessing and reducing the cost of production for gene therapies. 🤝 The organization collaborates with partners in various fields to advance their research. ⚙️ Exciting developments include producing AAV in plants and using artificial intelligence to optimize bioreactors. ❌ The industry faces challenges such as improving the full-to-empty ratio of virus capsids. ❗️ Revah comments on the Pfizer incident and assures that Généthon is closely monitoring safety in their own clinical trial.
Sartorius and Sanofi Revolutionize Drug Manufacturing!
🔬 Sartorius teams up with Sanofi to revolutionize drug manufacturing! 🌍💼 The collaboration aims to improve efficiency and sustainability. 🚀🏭
Swiss Antibody Specialist Secures CHF 45m Funding for Groundbreaking Research
💰 Swiss antibody specialist Memo Therapeutics AG secures CHF 45m in Series C financing, including CHF 20m from new investors. 🧪💉🌡️
Revolutionary Vertical Bioreactors Slash Cell Therapy Costs
📰 Vertical bioreactors could revolutionize cell therapy, reducing costs and improving oxygen delivery and cell growth. 🚀👨🔬⚙️
